Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Pneumococcal vaccine

This page shows the latest Pneumococcal vaccine news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s Prevnar-13 successor takes aim at Merck rival

Pfizer’s Prevnar-13 successor takes aim at Merck rival

Rivals look to broaden coverage across strains. Pfizer just got a leg-up in its race with Merck &Co to bring a new-generation pneumococcal vaccine to the US market after ... is in pursuit of PCV-15 (also known as V114), a 15-valent candidate that Merck

Latest news

  • Takeda's once-weekly DPP-4 inhibitor cleared in first market Takeda's once-weekly DPP-4 inhibitor cleared in first market

    The company also won Japanese approval for acne therapy Duac Combination Gel (clindamycin and benzoyl peroxide) and pneumococcal conjugate paediatric vaccine Synflorix. -

  • Pfizer's Prevenar 13 price cut slammed by MSF Pfizer's Prevenar 13 price cut slammed by MSF

    Pfizer has reduced the price of its pneumococcal vaccine Prevenar 13 for an immunisation programme targeting low-income countries, but has been criticised for not going far enough. ... However, medical charity Medecins Sans Frontieres (MSF) said the

  • CHMP thumbs up for Novo's obesity drug Saxenda CHMP thumbs up for Novo's obesity drug Saxenda

    Prevenar 13 also backed. Meanwhile, the CHMP has also issued a positive opinion for an application by Pfizer to extend the indications for its pneumococcal vaccine Prevenar 13 to include the ... prevention of pneumonia caused by the 13 pneumococcal

  • Call for GSK and Pfizer to reduce vaccine price Call for GSK and Pfizer to reduce vaccine price

    MSF campaigns to lower cost of pneumococcal shot to $5 per child in developing countries. ... with the Reach Every Child conference that will bring leading vaccine donors together in Berlin next week.

  • US panel backs pneumococcal vaccines for seniors US panel backs pneumococcal vaccines for seniors

    Adults over 65 who have not previously received pneumococcal vaccine - or whose previous vaccination history is unknown - should receive a dose of Prevnar 13 first, followed by a dose of Pneumovax ... The ACIP decision comes shortly after European

More from news
Approximately 1 fully matching, plus 33 partially matching documents found.

Latest Intelligence

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    26.6. ‡SK Chemicals/ Sanofi Pasteur. Collaboration. Pneumococcal conjugate vaccine (PCV). 23.

  • A tailored approach to the BRIC markets A tailored approach to the BRIC markets

    In 2009, GSK signed a 1.5bn deal with the Brazilian government to provide Syflorix, its vaccine for paediatric pneumococcal disease, at around a third of the price it charged in ... Europe. The deal guaranteed GSK a set price and set volumes for the

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Quick links

Infographics

Multimedia